Pancreatic Cancer Research

ResearcherWuhan UniversityActive in the last 2 years

Wenjing Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2583-4362; OpenAlex author ID A5101781500. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 4

  1. Breaking the immune desert: Strategies for overcoming the immunological challenges of pancreatic cancer. First author DOI 10.1016/j.bbcan.2025.189353↗
  2. METTL3/IGF2BP3 mediates ORC6 via N6-methyladenosine modification to promote the progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gene.2025.149468↗
  3. Pyroptosis-related genes regulate proliferation and invasion of pancreatic cancer and serve as the prognostic signature for modeling patient survival. Co-author DOI 10.1007/s12672-022-00495-0↗
  4. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fgene.2021.639246↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyong Yang · 2 shared papers, 2022–2025 · strength 0.39
  2. Haibang Pan · 1 shared paper, 2025 · strength 0.33
  3. Tianming Wang · 1 shared paper, 2025 · strength 0.33
  4. Zhi‐Nan Chen · 1 shared paper, 2025 · strength 0.23
  5. Yang Shi · 1 shared paper, 2025 · strength 0.23
  6. Jingwei Zhang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.